{"id":34923,"date":"2016-12-01T11:11:41","date_gmt":"2016-12-01T03:11:41","guid":{"rendered":"http:\/\/www.chinamoneynetwork.com\/?p=58472"},"modified":"2016-12-01T11:11:41","modified_gmt":"2016-12-01T03:11:41","slug":"cmb-international-sdic-unit-join-75m-series-b-round-in-chinas-novogene-technology","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2016\/12\/01\/cmb-international-sdic-unit-join-75m-series-b-round-in-chinas-novogene-technology\/","title":{"rendered":"CMB International, SDIC Unit Join $75M Series B Round In China's Novogene Technology"},"content":{"rendered":"<img width=\"429\" height=\"333\" src=\"http:\/\/www.chinamoneynetwork.com\/wp-content\/uploads\/healthcare000oo-1.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"healthcare000oo\" style=\"display: block; margin: auto; margin-bottom: 5px;\" srcset=\"http:\/\/www.chinamoneynetwork.com\/wp-content\/uploads\/healthcare000oo-1.jpg 429w, http:\/\/www.chinamoneynetwork.com\/wp-content\/uploads\/healthcare000oo-1-300x233.jpg 300w\" sizes=\"(max-width: 429px) 100vw, 429px\" \/>China Merchants Bank's CMB International Capital Management, a unit of State Development &#038; Investment Corporation (SDIC) and Sigma Square Capital have invested RMB515 million (US$75 million) in a series B funding round in Beijing-based Novogene Technology, a commercial genomic services provider. SDIC and Sigma Square Capital invested via SDIC Innovation Investment Management and Shanghai Sigma [&#8230;]<p><br>Visit <a href=\"http:\/\/www.chinamoneynetwork.com\/\" title=\"China Money Network\"><b>ChinaMoneyNetwork.com<\/b><\/a> for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter <a href=\"http:\/\/www.twitter.com\/chinamoneypod\" title=\"Follow China Money Network on Twitter\">@chinamoneypod<\/a> subscribe to all episodes on <a href=\"http:\/\/www.itunes.com\/podcast?id=451002399\" title=\"Download and listen to China Money Podcast on iTunes\">iTunes<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"429\" height=\"333\" src=\"http:\/\/www.chinamoneynetwork.com\/wp-content\/uploads\/healthcare000oo-1.jpg\" alt=\"healthcare000oo\">China Merchants Bank's CMB International Capital Management, a unit of State Development &amp; Investment Corporation (SDIC) and Sigma Square Capital have invested RMB515 million (US$75 million) in a series B funding round in Beijing-based Novogene Technology, a commercial genomic services provider. SDIC and Sigma Square Capital invested via SDIC Innovation Investment Management and Shanghai Sigma [&hellip;]<\/p>\n<p>Visit <a href=\"http:\/\/www.chinamoneynetwork.com\/\" title=\"China Money Network\"><b>ChinaMoneyNetwork.com<\/b><\/a> for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter <a href=\"http:\/\/www.twitter.com\/chinamoneypod\" title=\"Follow China Money Network on Twitter\">@chinamoneypod<\/a> subscribe to all episodes on <a href=\"http:\/\/www.itunes.com\/podcast?id=451002399\" title=\"Download and listen to China Money Podcast on iTunes\">iTunes<\/a>.<\/p>\n","protected":false},"author":167,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[807,194,1623],"tags":[7593,5256,8912],"class_list":["post-34923","post","type-post","status-publish","format-standard","hentry","category-investments","category-news-chinese-law","category-venture-capital","tag-fund-news","tag-healthcare","tag-sdic"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/34923"}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/167"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=34923"}],"version-history":[{"count":2,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/34923\/revisions"}],"predecessor-version":[{"id":34956,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/34923\/revisions\/34956"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=34923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=34923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=34923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}